Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 6B3 variant 3 (CYP6B3v3) is a specialized enzyme found in the black swallowtail butterfly, Papilio polyxenes, where it plays a critical role in the detoxification of plant-derived toxins (Hung et al., 1995). Specifically, it metabolizes furanocoumarins, which are defensive chemicals produced by plants in the Apiaceae and Rutaceae families that can cause DNA damage upon UV activation (Wen et al., 2006). CYP6B3v3 is a monooxygenase that converts these hydrophobic toxins into more water-soluble metabolites, allowing the insect to feed on otherwise toxic host plants (Li et al., 2003). While closely related to CYP6B1, CYP6B3v3 has a broader substrate specificity, enabling the metabolism of both linear and angular furanocoumarins, albeit with lower efficiency (Wen et al., 2006). The expression of this enzyme is highly inducible by the presence of furanocoumarins in the larval diet, representing a key evolutionary adaptation to chemical warfare between plants and herbivores (Hung et al., 1995). In agricultural and toxicological research, CYP6B3v3 serves as a model for understanding metabolic resistance and is a potential target for synergists designed to inhibit detoxification enzymes in pests (Scott et al., 1998).
Catalyzes the NADPH-dependent monooxygenation of furanocoumarins to facilitate their metabolic detoxification and excretion.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 6B3 variant 3 (CYP6B3v3).